Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3-day Malarone schedule for malaria prophylaxis in adult travelers
ACTRN12616000640404Phase 4Completed
- Sponsor
- Colleen Lau
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of atovaquone + proguanil in malaria, sponsored by Colleen Lau. Primary endpoints: Tolerability of the 3-day schedule of atovaquone-proguanil for malaria prophylaxis, Acceptability of the 3-day schedule of atovaquone-proguanil for malaria prophylaxis and 1 more. Started Oct 2016; status: completed.
02
Drugs
atovaquone + proguanil
03
Conditions
malaria
Beyond the preview
Go deeper on ACTRN12616000640404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000640404.